Variant report

Variant	nsv610156
Chromosome Location	chr8:8163243-8207339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:43)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:43 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:8145925..8147772-chr8:8172599..8174671,2	MCF-7	breast:
2	chr8:8176191..8177964-chr8:8181508..8183686,2	MCF-7	breast:
3	chr8:8147577..8148485-chr8:8171987..8172936,5	MCF-7	breast:
4	chr8:8182749..8184477-chr8:8188619..8190781,2	K562	blood:
5	chr8:8151935..8153565-chr8:8167280..8169778,2	MCF-7	breast:
6	chr8:8184859..8186601-chr8:8189664..8191864,2	K562	blood:
7	chr8:8174141..8174643-chr8:8351385..8352080,2	K562	blood:
8	chr8:8152575..8156744-chr8:8165539..8169727,4	MCF-7	breast:
9	chr8:8188047..8190192-chr8:8196636..8199036,2	K562	blood:
10	chr8:8193329..8194898-chr8:8200679..8203129,2	K562	blood:
11	chr8:8168175..8169902-chr8:8242938..8245869,2	MCF-7	breast:
12	chr8:8170459..8174320-chr8:8242480..8245231,3	MCF-7	breast:
13	chr8:8187214..8189069-chr8:8194011..8195782,2	K562	blood:
14	chr8:8145045..8147805-chr8:8168275..8170393,2	MCF-7	breast:
15	chr8:8192658..8194970-chr8:8198409..8200233,2	K562	blood:
16	chr8:8151537..8155554-chr8:8160869..8164322,5	MCF-7	breast:
17	chr8:8147089..8149132-chr8:8190153..8192051,2	MCF-7	breast:
18	chr8:8187214..8189069-chr8:8194011..8195782,2	K562	blood:
19	chr8:8155614..8158517-chr8:8163567..8165783,2	MCF-7	breast:
20	chr8:8206715..8208610-chr8:8215544..8217436,2	MCF-7	breast:
21	chr8:8086683..8088508-chr8:8193858..8196209,2	MCF-7	breast:
22	chr8:8193329..8194898-chr8:8200679..8203129,2	K562	blood:
23	chr8:8152309..8154624-chr8:8177640..8180074,2	MCF-7	breast:
24	chr8:8151372..8154142-chr8:8175847..8177840,2	MCF-7	breast:
25	chr8:8147727..8148466-chr8:8172098..8172982,3	MCF-7	breast:
26	chr8:8191451..8193735-chr8:8198247..8200016,2	MCF-7	breast:
27	chr8:8184859..8186601-chr8:8189664..8191864,2	K562	blood:
28	chr8:8182749..8184477-chr8:8188619..8190781,2	K562	blood:
29	chr8:8147573..8150272-chr8:8166843..8168780,2	MCF-7	breast:
30	chr8:8163385..8165177-chr8:8167014..8169330,2	MCF-7	breast:
31	chr8:8146657..8147172-chr8:8172119..8172832,2	MCF-7	breast:
32	chr8:8146324..8147133-chr8:8168152..8168656,2	MCF-7	breast:
33	chr8:8146402..8147201-chr8:8172122..8172875,3	MCF-7	breast:
34	chr8:8163385..8165177-chr8:8167014..8169330,2	MCF-7	breast:
35	chr8:8188047..8190192-chr8:8196636..8199036,2	K562	blood:
36	chr8:8192658..8194970-chr8:8198409..8200233,2	K562	blood:
37	chr8:8147577..8148479-chr8:8171987..8172936,6	MCF-7	breast:
38	chr8:8191570..8193899-chr8:8241240..8244874,3	MCF-7	breast:
39	chr8:8172038..8172585-chr8:8365267..8365778,2	MCF-7	breast:
40	chr8:8146352..8147329-chr8:8172122..8173007,5	MCF-7	breast:
41	chr8:8130421..8131300-chr8:8175825..8176932,3	K562	blood:
42	chr8:8176191..8177964-chr8:8181508..8183686,2	MCF-7	breast:
43	chr8:8191451..8193735-chr8:8198247..8200016,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000182319	chromatin interactions

Extended variants
information (count: 2320 )
Associated
traits (count: 142 )

Variant overlapped rSNPs/rCNVs (count:2320 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10104607	chr8:8163243-8163244	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs557125529	chr8:8163244-8163245	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs573366351	chr8:8163248-8163249	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs144357507	chr8:8163273-8163274	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs146604109	chr8:8163283-8163284	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs10104714	chr8:8163316-8163317	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs572490843	chr8:8163320-8163321	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs141322069	chr8:8163327-8163328	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs565438944	chr8:8163359-8163360	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs145043204	chr8:8163383-8163384	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs550854940	chr8:8163420-8163421	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs557877955	chr8:8163436-8163437	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs561483735	chr8:8163460-8163461	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs530191395	chr8:8163488-8163489	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs547099500	chr8:8163497-8163498	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs567011605	chr8:8163506-8163507	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs538652651	chr8:8163532-8163533	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs138738454	chr8:8163570-8163571	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs571407953	chr8:8163579-8163580	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs538557228	chr8:8163596-8163597	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs537365523	chr8:8163600-8163601	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs187012401	chr8:8163639-8163640	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs573481770	chr8:8163644-8163645	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs536077492	chr8:8163659-8163660	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs552644683	chr8:8163665-8163666	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs572650750	chr8:8163675-8163676	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs544631657	chr8:8163687-8163688	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs192265181	chr8:8163707-8163708	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs556245890	chr8:8163730-8163731	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs544912049	chr8:8163744-8163745	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs561601671	chr8:8163760-8163761	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs530305761	chr8:8163763-8163764	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs62496021	chr8:8163773-8163774	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs17149566	chr8:8163779-8163780	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs143613542	chr8:8163787-8163788	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs6981269	chr8:8163828-8163829	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs148047628	chr8:8163846-8163847	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs182917197	chr8:8163856-8163857	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs77035506	chr8:8163886-8163887	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs187214356	chr8:8163888-8163889	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs143640755	chr8:8163897-8163898	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs193124554	chr8:8163905-8163906	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs540296463	chr8:8163936-8163937	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs552754923	chr8:8163939-8163940	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs572810920	chr8:8163942-8163943	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs538742668	chr8:8163987-8163988	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs558240784	chr8:8164004-8164005	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs552534970	chr8:8164021-8164022	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs566000617	chr8:8164024-8164025	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs543909555	chr8:8164026-8164027	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:142)

Disease	PMID	Source
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16774939	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Bladder cancer	21909424	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
Schizophrenia	21346763	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	20164919	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Williams Syndrome	20824207	CNVD

Chromatin state (count:2535 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:8154800-8167400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr8:8156200-8167800	Weak transcription	Placenta	Placenta
3	chr8:8156800-8167600	Weak transcription	Sigmoid Colon	Sigmoid Colon
4	chr8:8157800-8167400	Weak transcription	Rectal Mucosa Donor 31	rectum
5	chr8:8161400-8165000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr8:8162600-8163400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr8:8162600-8163400	Weak transcription	Stomach Mucosa	stomach
8	chr8:8162600-8163800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr8:8162600-8164000	Enhancers	HepG2	liver
10	chr8:8162600-8164400	Enhancers	Skeletal Muscle Female	skeletal muscle
11	chr8:8162600-8164600	Enhancers	Fetal Lung	lung
12	chr8:8162800-8164000	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr8:8162800-8164400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr8:8162800-8164400	Enhancers	NH-A	brain
15	chr8:8162800-8164400	Enhancers	Osteobl	bone
16	chr8:8163000-8163400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr8:8163000-8163400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr8:8163000-8163600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr8:8163000-8163800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
20	chr8:8163000-8164200	Enhancers	HUVEC	blood vessel
21	chr8:8163000-8164400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr8:8163200-8163400	Bivalent Enhancer	Fetal Muscle Leg	muscle
23	chr8:8163200-8163400	Enhancers	Lung	lung
24	chr8:8163200-8163600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr8:8163200-8163600	Enhancers	Fetal Stomach	stomach
26	chr8:8163200-8163800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr8:8163200-8163800	Enhancers	Fetal Brain Male	brain
28	chr8:8163200-8163800	Enhancers	Ovary	ovary
29	chr8:8163200-8163800	Enhancers	Psoas Muscle	Psoas
30	chr8:8163200-8163800	Enhancers	Right Atrium	heart
31	chr8:8163200-8163800	Enhancers	Skeletal Muscle Male	skeletal muscle
32	chr8:8163200-8163800	Flanking Active TSS	A549	lung
33	chr8:8163200-8163800	Enhancers	Hela-S3	cervix
34	chr8:8163200-8164000	Enhancers	Brain Anterior Caudate	brain
35	chr8:8163200-8164000	Enhancers	Colon Smooth Muscle	Colon
36	chr8:8163200-8164000	Enhancers	Fetal Kidney	kidney
37	chr8:8163200-8164000	Enhancers	NHLF	lung
38	chr8:8163200-8164200	Enhancers	Muscle Satellite Cultured Cells	--
39	chr8:8163200-8164200	Enhancers	NHDF-Ad	bronchial
40	chr8:8163200-8164400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
41	chr8:8163200-8164600	Enhancers	Adipose Nuclei	Adipose
42	chr8:8163400-8163600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr8:8163400-8163600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr8:8163400-8163800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr8:8163400-8163800	Enhancers	Stomach Mucosa	stomach
46	chr8:8163400-8163800	Enhancers	HMEC	breast
47	chr8:8163400-8163800	Enhancers	HSMM	muscle
48	chr8:8163400-8164000	Enhancers	HSMMtube	muscle
49	chr8:8163400-8164400	Enhancers	Fetal Muscle Leg	muscle
50	chr8:8163400-8167600	Weak transcription	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links